Pan-cancer analysis and experimental validation identify CYP19A1 as a prognostic biomarker and oncogenic driver associated with tumor immune microenvironment regulation in gastrointestinal cancers

Scritto il 27/04/2026
da Zongrong Lin

No abstract

Discov Oncol. 2026 Apr 27. doi: 10.1007/s12672-026-04998-y. Online ahead of print.

NO ABSTRACT

PMID:42043681 | DOI:10.1007/s12672-026-04998-y